Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 

IBCSG 26-02 / BIG 4-02 (PERCHE) 

A phase III trial evaluating the role of chemotherapy as adjuvant therapy for premenopausal women with endocrine responsive breast cancer who receive endocrine therapy

Premenopausal Endocrine Responsive Chemotherapy Trial (PERCHE)

DESIGN

please click on the picture to see a larger version

Results & Publications


Posters


Presentations


Publications

 

Study Chairs
BIG: Dr. Rosalba Torrisi - Milano, Italy
US Intergroup: Dr. Edith A. Perez - Jacksonville, USA

Statistician
Dr. Meredith Regan

Lead Trial Coordinator
Holly Shaw

Data Managers
Karolyn Scott, Monica Greco, Adriana Mora de Karausch, Patricia Gonzales

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: ibcsg24-26_STP@fstrf.org

Date of Activation
August 4, 2003

Date of Closure
December 31, 2006

Targeted Accrual
1750 patients

Final Accrual
29 patients


Results Publications Results & Publications
Other Pathology


News

23.03.2018:
The next IBCSG Annual Meeting will take place in Barcelona, Spain on March 23 and 24, 2018

03.09.2017:
RACE FOR LIFE - mit Power gegen Krebs am 3. September 2017 in Bern  

15.06.2017:
PINK GOLF TOUR 2017 für die Brustkrebs-Prävention  

All News

 
  Print